The European Commission (EC) has authorised the use of ViiV Healthcare’s Vocabria (cabotegravir long-acting injections) plus ...
Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...
Sir Jonathan Van-Tam will work across the Health & Life Sciences client portfolio as it growsLONDON, Feb. 03, 2025 (GLOBE ...
Climate displacement is not a distant or hypothetical threat; it is a rapidly escalating health emergency. The pharmaceutical ...
A jab given to patients to battle RSV through the NHS could potentially cause a disabling condition known as Guillain-Barré ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback